Literature DB >> 22082520

Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism.

Paul D Stein1, Fadi Matta.   

Abstract

The proportion of hospitalized patients with pulmonary embolism (PE) is increasing. Whether this represents more admissions with PE or more diagnoses made in hospitalized patients is uncertain. The proportion of hospitalized patients with deep venous thrombosis has decreased precipitously as a result of home treatment. Asians and Native Americans have a lower incidence of PE than whites or African Americans. The incidence of PE increases exponentially with age, but no age group, including infants and children, is immune. Several medical illnesses have now been shown to be associated with a higher risk for venous thromboembolism. Epidemiologic data and new information on risk factors provide insight into making an informed clinical assessment and evaluation for antithrombotic prophylaxis.

Entities:  

Mesh:

Year:  2011        PMID: 22082520     DOI: 10.1016/j.ccc.2011.09.006

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  5 in total

1.  Pulmonary embolism response teams.

Authors:  Nosheen Reza; David M Dudzinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

2.  Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism.

Authors:  Xiaowei Gong; Haiyan Wang; Yadong Yuan
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

3.  Multilocus genetic risk scores for venous thromboembolism risk assessment.

Authors:  José Manuel Soria; Pierre-Emmanuel Morange; Joan Vila; Juan Carlos Souto; Manel Moyano; David-Alexandre Trégouët; José Mateo; Noémi Saut; Eduardo Salas; Roberto Elosua
Journal:  J Am Heart Assoc       Date:  2014-10-23       Impact factor: 5.501

4.  Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism.

Authors:  Yaoqian Cao; Haiyan Zhao; Wanpeng Gao; Yan Wang; Jie Cao
Journal:  Patient Prefer Adherence       Date:  2014-02-28       Impact factor: 2.711

5.  Outcome of Sub-Massive Pulmonary Thromboemboli in Patients Who Received Thrombolytic and or Non-Thrombolytic Therapy.

Authors:  Hasan Allah Sadeghi; Mona Heidarali; Fusieh Faraji; Behshid Ghadrdoost; Maryam Shojaeifard
Journal:  Res Cardiovasc Med       Date:  2016-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.